Kidney Precision Medicine Meeting
Despite many academic and industry efforts to treat acute and chronic kidney disease, therapies remain limited. This conference aims to bring together basic, clinical, and translational scientists, health care professionals, industry and government representatives, and patients – all of whom are interested in the treatment of acute and chronic kidney disease:
- To recognize the heterogeneity of acute and chronic kidney disease and the importance in differentiating such heterogeneity so that precise treatments can be developed and provided to individual patients.
- To determine the quantity and usability of currently available kidney tissues obtained from patients with acute and chronic kidney disease (including transplant donors, partial nephrectomy for renal cell carcinoma).
- To discuss the need, challenges, and barriers in obtaining research biopsies from patients with acute and chronic kidney disease, as well as the negative consequence of not obtaining kidney tissues in the current and future treatment of those patients.
- To establish the scientific and clinical quality control/assurance metrics and training needed for setting up a network to obtain kidney research biopsies.
- To discuss the phasing and priority needed to move the field forward.
Information regarding Hotel reservations at the Doubletree by Hilton Bethesda can be found under the Directions/Travel tab. The last day to reserve a room at the group rate is Friday, April 29.
Double Tree Hotel
8120 Wisconsin Ave
Bethesda, MD 20814
Chris Ketchum, Ph.D.
Michael Flessner, M.D., Ph.D.
Paul L. Kimmel, M.D.
Krystyna Rys-Sikora, Ph.D.
Yining Xie, M.D.
Rob Watson, CMP
The Scientific Consulting Group, Inc.